SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?


To: smh who wrote (1021)5/6/1999 10:06:00 AM
From: Scott H. Davis  Respond to of 1972
 
Looks like the prostate news is being recieved favorably. Scott (EOM)



To: smh who wrote (1021)5/18/1999 10:29:00 AM
From: Scott H. Davis  Read Replies (1) | Respond to of 1972
 
Vical Tests Promising Gene-Based Drug Candidate for Kidney Cancer.
Preliminary Clinical Trial Data For Leuvectin Presented at ASCO meeting. biz.yahoo.com